美國VIVUS
VIVUS公司是一家生物制藥公司,商業化和開發創新下一代療法,以解決未滿足的需求肥胖,睡眠呼吸暫停,糖尿病和性健康,美國,歐洲和世界其他市場。
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. Qsymia is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.